Abstract A042: Formulation of FLAG-003 Tablets to support Phase I/II Clinical Testing in Children with DIPG
Year: 2026
Type: conference-abstract
Source: Cancer Research
Author: Frank L. Sorgi
Institution: Flag Therapeutics (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7140149088
Cites:
Cited by:
Related to: